Literature DB >> 27942517

Troubleshooting an isolate prolongation of activated partial thromboplastin time in a patient with acute myocardial infarction-a paradigmatic case report.

Giovanni Poli1, Piero Castiglioni2, Martina Montagnana1, Emmanuel J Favaloro3, Giuseppe Lippi1.   

Abstract

We describe here the case of a 46-year-old man admitted to the emergency department (ED) and diagnosed with a non-ST elevation myocardial infarction. Before referring the patient to the coronary care unit and initiating antiplatelet and anticoagulant therapy, a highly prolonged activated partial thromboplastin time (APTT) was observed among results of laboratory testing. Results of mixing test showed complete correction of APTT, thus ruling out the presence of inhibitors of blood coagulation. On the following day, second line coagulation testing revealed normal activity of all clotting factors except factor XII, the concentration of which was found to be 1.5%. This result was suggestive for a diagnosis of inherited factor XII deficiency, thus highlighting the importance of combining clinical history, symptoms and results of first-line coagulation tests in similar emergency conditions.

Entities:  

Keywords:  Myocardial infarction; activated partial thromboplastin time (APTT); factor XII; laboratory diagnostics; mixing test

Year:  2016        PMID: 27942517      PMCID: PMC5124628          DOI: 10.21037/atm.2016.11.17

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN: 2305-5839


  10 in total

1.  Preoperative screening: the rationale of measuring APTT in risk assessment.

Authors:  G Lippi; M Franchini; P Brazzarola; F Manzato
Journal:  Haematologica       Date:  2001-03       Impact factor: 9.941

Review 2.  Laboratory testing in the era of direct or non-vitamin K antagonist oral anticoagulants: a practical guide to measuring their activity and avoiding diagnostic errors.

Authors:  Emmanuel J Favaloro; Giuseppe Lippi
Journal:  Semin Thromb Hemost       Date:  2015-02-19       Impact factor: 4.180

3.  Quality and safety issues of direct oral anticoagulants in the emergency department.

Authors:  Gianfranco Cervellin; Mario Benatti; Laura Bonfanti; Giuseppe Lippi
Journal:  Semin Thromb Hemost       Date:  2015-04-03       Impact factor: 4.180

Review 4.  Unfractionated heparin for the treatment of venous thromboembolism: best practices and areas of uncertainty.

Authors:  Adam Cuker
Journal:  Semin Thromb Hemost       Date:  2012-06-20       Impact factor: 4.180

Review 5.  Inherited disorders of blood coagulation.

Authors:  Giuseppe Lippi; Massimo Franchini; Martina Montagnana; Emmanuel J Favaloro
Journal:  Ann Med       Date:  2011-05-17       Impact factor: 4.709

6.  Accelerated diagnostic protocol using high-sensitivity cardiac troponin T in acute chest pain patients.

Authors:  Bernadette Meller; Louise Cullen; William A Parsonage; Jaimi H Greenslade; Sally Aldous; Tobias Reichlin; Karin Wildi; Raphael Twerenbold; Cedric Jaeger; Petra Hillinger; Philip Haaf; Christian Puelacher; Vera Kern; Katharina Rentsch; Fabio Stallone; Maria Rubini Gimenez; Paola Ballarino; Stefano Bassetti; Astrid Walukiewicz; Richard Troughton; Christopher J Pemberton; A Mark Richards; Kevin Chu; Christopher M Reid; Martin Than; Christian Mueller
Journal:  Int J Cardiol       Date:  2015-02-11       Impact factor: 4.164

7.  Mixing tests: diagnostic aides in the investigation of prolonged prothrombin times and activated partial thromboplastin times.

Authors:  Geoffrey Kershaw; Daniel Orellana
Journal:  Semin Thromb Hemost       Date:  2013-03-02       Impact factor: 4.180

8.  Of MIs and men--a historical perspective on the diagnostics of acute myocardial infarction.

Authors:  Gianfranco Cervellin; Giuseppe Lippi
Journal:  Semin Thromb Hemost       Date:  2014-06-26       Impact factor: 4.180

9.  Activated partial thromboplastin time: new tricks for an old dogma.

Authors:  Giuseppe Lippi; Emmanuel J Favaloro
Journal:  Semin Thromb Hemost       Date:  2008-12-15       Impact factor: 4.180

Review 10.  Factor XII in Hemostasis and Thrombosis: Active Player or (Innocent) Bystander?

Authors:  Elisa Danese; Martina Montagnana; Giuseppe Lippi
Journal:  Semin Thromb Hemost       Date:  2016-04-13       Impact factor: 4.180

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.